This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The IL-17 family in diseases: from bench to bedside
Signal Transduction and Targeted Therapy Open Access 11 October 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Bambouskova, M. et al. Electrophilic properties of itaconate and derivates regulate the IκBζ–ATF3 inflammatory axis. Nature 556, 501–504 (2018)
Further reading
Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113–117 (2018)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bordon, Y. Itaconate charges down inflammation. Nat Rev Immunol 18, 360–361 (2018). https://doi.org/10.1038/s41577-018-0016-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41577-018-0016-4
This article is cited by
-
The IL-17 family in diseases: from bench to bedside
Signal Transduction and Targeted Therapy (2023)
-
ROS-associated immune response and metabolism: a mechanistic approach with implication of various diseases
Archives of Toxicology (2020)